Patients with opioid use disorder are significantly more likely to stick with their treatment plan when offered buprenorphine via telemedicine, according to a new study in The American Journal of Drug and Alcohol Abuse.
The…
Culturally competent behavioral health provider ReKlame Health is expanding its addiction treatment services into the home, the company exclusively told MedCity News on Monday.
New York City-based ReKlame Health offers virtual mental health and addiction…
About 37% of Americans live in areas where there is a shortage of mental health providers. By 2025, the U.S. will be short about 31,000 full-time equivalent mental health practitioners, said Miriam Delphin-Rittmon, assistant…
Continue Reading
Jeremy Bloom, CEO, NorthSight RecoveryThe United States only represents five percent of the world’s population; however, Americans consume 80 percent of the world’s opioids.1 The U.S. is the world’s leader in the use of…
Continue Reading
The Department of Justice filed a lawsuit Monday against Rite Aid, accusing the pharmacy chain of filling hundreds of thousands of opioid prescriptions that had “obvious, and often multiple, red flags.”
Rite Aid is one…
In a fee-for-service world, it can be hard for health systems and other providers to prioritize caring for the homeless population, who carry some of the worst health risks of any other population in…
Continue Reading
Health insurer Cigna added behavioral health provider ReKlame Health to its network in an effort to expand access for underserved communities, the companies announced Thursday.
New York City-based ReKlame Health is a virtual provider for…
What You Should Know:– ReKlame Health, a provider of culturally competent, affordable and empathetic behavioral healthcare for BIPOC communities, announced that it has joined Cigna as an in-network mental healthcare provider in New York,…
Continue Reading
NZ eases access to mental health, addiction supportNew Zealand’s Ministry of Health has officially launched an online portal for accessing the services provided by the Access and Choice programme.
The said website puts all Access…
The pain drug market has many products, but there’s still a need for pills with better properties, such as avoiding addiction. Eli Lilly sees potential in the non-opioid pain drug research from Confo Therapeutics…
Continue Reading
